Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report
ContributorsJornayvaz, François
; Assouline, Benjamin; Pugin, Jérôme; Gariani, Karim
Published inBMC Endocrine Disorders, vol. 20, no. 1, 155
Publication date2020
Abstract
Keywords
- Betacoronavirus/isolation & purification
- COVID-19
- Coronavirus Infections/complications/transmission/virology
- Diabetes Mellitus
- Type 2/drug therapy/epidemiology/pathology/virology
- Dose-Response Relationship
- Drug
- Humans
- Hypoglycemic Agents/therapeutic use
- Insulin/therapeutic use
- Male
- Middle Aged
- Pandemics
- Pneumonia
- Viral/complications/transmission/virology
- Prognosis
- SARS-CoV-2
Citation (ISO format)
JORNAYVAZ, François et al. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report. In: BMC Endocrine Disorders, 2020, vol. 20, n° 1, p. 155. doi: 10.1186/s12902-020-00632-2
Main files (1)
Article (Published version)
Identifiers
- PID : unige:154934
- DOI : 10.1186/s12902-020-00632-2
- PMID : 33066762
Additional URL for this publicationhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563905/
Journal ISSN1472-6823
